このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Dr. Reddy's Laboratories マネジメント
マネジメント 基準チェック /34
Dr. Reddy's Laboratories'の CEO はErez Israeliで、 Apr2018年に任命され、 の在任期間は 6.17年です。 は、会社の株式の0.022%を直接所有しており、その価値は₹ 223.94M 。経営陣と取締役会の平均在任期間はそれぞれ6.2年と3.9年です。
主要情報
Erez Israeli
最高経営責任者
₹197.1m
報酬総額
| CEO給与比率 | n/a |
| CEO在任期間 | 6.2yrs |
| CEOの所有権 | 0.04% |
| 経営陣の平均在職期間 | 6.2yrs |
| 取締役会の平均在任期間 | 3.9yrs |
経営陣の近況
Recent updates
Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00
May 26
Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
May 10With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case
May 06There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding
Apr 18Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 02Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?
Jan 19Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E
Jan 01Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet
Oct 21If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Oct 03Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt
Jul 14Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
Jun 24Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year
Jun 10Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
May 27Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00
May 13Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Apr 11If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Mar 06These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well
Jan 10If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Dec 05Is Dr. Reddy's Laboratories (NSE:DRREDDY) A Risky Investment?
Sep 28Do Dr. Reddy's Laboratories' (NSE:DRREDDY) Earnings Warrant Your Attention?
Aug 17Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Shares Could Be 33% Above Their Intrinsic Value Estimate
Jul 21Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹30.00
Jul 08Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Larger Dividend Than Last Year At ₹30.00
Jun 22CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | ₹197m | n/a | ₹56b |
| Dec 31 2023 | n/a | n/a | ₹52b |
| Sep 30 2023 | n/a | n/a | ₹51b |
| Jun 30 2023 | n/a | n/a | ₹47b |
| Mar 31 2023 | ₹195m | n/a | ₹45b |
| Dec 31 2022 | n/a | n/a | ₹36b |
| Sep 30 2022 | n/a | n/a | ₹31b |
| Jun 30 2022 | n/a | n/a | ₹30b |
| Mar 31 2022 | ₹127m | n/a | ₹24b |
| Dec 31 2021 | n/a | n/a | ₹26b |
| Sep 30 2021 | n/a | n/a | ₹19b |
| Jun 30 2021 | n/a | n/a | ₹17b |
| Mar 31 2021 | ₹120m | n/a | ₹17b |
| Dec 31 2020 | n/a | n/a | ₹21b |
| Sep 30 2020 | n/a | n/a | ₹15b |
| Jun 30 2020 | n/a | n/a | ₹19b |
| Mar 31 2020 | ₹195m | ₹107m | ₹19b |
| Dec 31 2019 | n/a | n/a | ₹16b |
| Sep 30 2019 | n/a | n/a | ₹27b |
| Jun 30 2019 | n/a | n/a | ₹21b |
| Mar 31 2019 | ₹123m | n/a | ₹19b |
報酬と市場: Erezの 総報酬 ($USD 2.34M ) は、 Indian市場 ($USD 1.05M ) の同規模の企業の平均を上回っています。
報酬と収益: Erezの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Erez Israeli (56 yo)
6.2yrs
在職期間
₹197,090,000
報酬
Mr. Erez Israeli, MBA has been Chief Executive Officer of Dr. Reddy's Laboratories Limited since August 1, 2019. Mr. Israeli served as Chief Operating Officer, Global Head Generics & PSAI Business and Memb...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Co-Chairman | 38.2yrs | ₹186.28m | 13.08% ₹ 132.5b | |
| Chairman of the Board & Member of the Management Council | 31.4yrs | ₹116.17m | 13.62% ₹ 138.0b | |
| CEO & Member of the Management Council | 6.2yrs | ₹197.09m | 0.041% ₹ 417.7m | |
| CFO & Member of Management Council | 3.5yrs | ₹64.66m | データなし | |
| Global Head of Quality and Pharmacovigilance & Member of the Management Council | less than a year | ₹6.15m | データなし | |
| CEO of API & Services & Member of Management Council | no data | ₹41.90m | データなし | |
| CEO of Branded Markets - India & Emerging Countries and Member of Management Council | no data | ₹82.74m | データなし | |
| EVP, Head of Corporate Communications | 7yrs | ₹65.21m | データなし | |
| Executive VP | 6.8yrs | ₹66.05m | データなし | |
| CEO of European Generics & Member of Management Council | no data | ₹63.09m | データなし | |
| Deputy CFO & Member of the Management Council | no data | ₹48.82m | データなし | |
| Global Head of Integrated Product Development Organisation & Member of the Management Council | no data | ₹55.63m | データなし |
6.2yrs
平均在職期間
56.5yo
平均年齢
経験豊富な経営陣: DRREDDYの経営陣は経験豊富で経験豊富です（平均在職期間は6.2年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Co-Chairman | 38.2yrs | ₹186.28m | 13.08% ₹ 132.5b | |
| Chairman of the Board & Member of the Management Council | 31.4yrs | ₹116.17m | 13.62% ₹ 138.0b | |
| Lead Independent Director | 17yrs | ₹16.68m | 0.0065% ₹ 65.7m | |
| Member of the Scientific Advisory Board | no data | ₹8.36m | データなし | |
| Independent Director | 1.8yrs | ₹18.77m | データなし | |
| Additional Independent Director | 5.4yrs | ₹13.34m | データなし | |
| Member of the Scientific Advisory Board | no data | データなし | データなし | |
| Independent & Non Whole-time Director | 5.7yrs | ₹17.10m | データなし | |
| Additional Independent Director | 2.4yrs | ₹14.18m | データなし | |
| Independent Director | 1.4yrs | ₹8.25m | データなし | |
| Additional Independent Director | 2.4yrs | ₹17.10m | データなし | |
| Director | 1.1yrs | ₹16.09m | データなし |
3.9yrs
平均在職期間
64yo
平均年齢
経験豊富なボード: DRREDDYの 取締役会 は 経験豊富 であると考えられます ( 3.9年の平均在任期間)。